Medical cannula market seen nearly doubling by 2036

By AI, Created 10:28 AM UTC, May 20, 2026, /AGP/ – Future Market Insights says the global medical cannula market will rise from $252.8 million in 2026 to $493.3 million by 2036 as minimally invasive procedures, outpatient care and safer device designs drive demand. Growth is strongest in emerging markets, while hospitals shift toward polymer-based cannulas and specialized airway and vascular access products.

Why it matters: - The medical cannula market is expanding as hospitals seek devices that support safer procedures, faster workflows and better patient outcomes. - Rising demand for minimally invasive care and outpatient procedures is increasing the need for cannulas across vascular access, airway management and surgery. - The shift toward polymer-based, procedure-specific devices reflects broader pressure to reduce complications and improve first-pass success rates.

What happened: - Future Market Insights projected the global medical cannula industry at $252.8 million in 2026. - The market is forecast to reach $493.3 million by 2036. - FMI projected a 6.9% compound annual growth rate from 2026 to 2036. - The release was issued March 30, 2026.

The details: - Guedel cannulas held a 27.8% market share in 2026, supported by their role in emergency airway management. - 18G gauge sizes accounted for 24.6% of the market in 2026 because they balance flow rate and insertion comfort. - Vascular access applications made up 74.2% of the market in 2026. - Medical cannula demand is tied to intravenous therapy, fluid management, blood sampling and medication delivery in hospitals. - Interventional cardiology and catheter-based procedures are increasing demand for specialized vascular cannulas with advanced insertion methods and coatings. - The market is segmented by product type, procedure, gauge size, material and end user. - Product categories include Guedel, Yankauer, Berman, Frazier and other cannulas. - Procedure categories include vascular access, surgery, intubation and suction. - Gauge sizes run from 14G to 26G. - Materials include latex, latex-free and neoprene. - End users include hospitals, ambulatory surgical centers and clinics. - India is projected to grow at 8.2% CAGR. - China is projected to grow at 6.7% CAGR. - Brazil is projected to grow at 7.1% CAGR. - The United States is forecast to grow at 6.3% CAGR. - Germany is projected to grow at 5.1% CAGR. - Prominent market players listed in the release include AdvaCare Pharma, Teleflex Incorporated, B. Braun SE, ResMed Inc. and Fisher & Paykel Healthcare Limited.

Between the lines: - The strongest growth is coming from emerging markets where hospital expansion, healthcare modernization and local device manufacturing are accelerating adoption. - In mature markets, growth is slower but still steady because providers continue to emphasize precision, digital integration and evidence-based protocols. - Competition appears to be shifting toward clinical evidence, usability and product customization rather than basic device availability. - Hospitals are prioritizing infection prevention, which favors cannulas with validated biocompatibility, appropriate gauge sizing and coatings that reduce complications.

What’s next: - Manufacturers are expected to keep moving away from traditional metal formats and toward biocompatible polymer-based options. - Product development is likely to focus on refined tips, specialized coatings and procedure-specific features. - Companies are likely to pursue research collaborations, narrower product lines and deeper partnerships with healthcare providers. - Procurement leaders and clinical directors will continue evaluating cannula portfolios as surgical volumes rise and infrastructure expands globally. - More information is available in the sample report and the full report.